| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2022 ( Subtotal = $150,736 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 5 | 7/26/2022 | NON-COMPETING CONTINUATION | $150,736 |
|
| Issue Date FY: 2021 ( Subtotal = $150,736 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 7/27/2021 | NON-COMPETING CONTINUATION | $150,736 |
|
| Issue Date FY: 2020 ( Subtotal = $150,736 ) |
| 2020 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 3 | 7/29/2020 | NON-COMPETING CONTINUATION | $150,736 |
|
| Issue Date FY: 2019 ( Subtotal = $145,299 ) |
| 2019 | 2019 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 2 | 7/12/2019 | NON-COMPETING CONTINUATION | $145,299 |
|
| Issue Date FY: 2018 ( Subtotal = $146,799 ) |
| 2018 | 2018 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 1 | 7/24/2018 | NEW | $146,799 |
|
|